This Symposium followed on our successful 2016 “VirginiaBrainRx” meeting in Richmond, and focused on current challenges and opportunities in drug discovery and development for cancer. The meeting included four keynote addresses from national leaders in the academy, industry and foundations, 20 invited talks from researchers from within the Commonwealth, and over 35 poster presentations.
The Symposium Program, which contains the Abstracts for all these presentations is now available.
This Symposium could not have taken place without the generous support of our Institutional Sponsors, for which we express our sincere gratitude!
- The University of Virginia (Cancer Center, School of Medicine, the Office of the Vice-President for Research, Department of Pharmacology, Tech Transfer Office, and the Fiske Drug Discovery Laboratory)
- Virginia Tech (College of Science, the Office of the Vice-President for Research and Innovation, and the Virginia Tech Carilion Research Institute)
- The Inova Schar Cancer Institute
- Virginia Commonwealth University (Office of Research & Innovation, School of Medicine, Massey Cancer Center)
- George Mason University
- Eastern Virginia Medical School
VirginiaCancerRx in the News!
John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017 conference “VirginiaRx.
Robert A. Kramer
Ph.D. Chief Scientific Officer of RAKramer Consulting LLC. Newton, PA. Formerly Global Head of Oncology Drug Discovery at Janssen (a Johnson & Johnson company)
Talk: “Cancer Drug Discovery and Development in the Immune Oncology era, this is not your father’s Oldsmobile”
Craig M. Crews
Ph.D. Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology, Departments of Chemistry and Pharmacology. Executive Director, Yale Center for Molecular Discovery. Yale University. New Haven, CT
Talk: “PROTACS: Induced Protein Degradation as a Therapeutic Strategy”
Barbara S. Slusher
Ph.D., Professor of Neurology, Medicine, Psychiatry, and Neuroscience. Director, Johns Hopkins Drug Discovery. Johns Hopkins University. Baltimore, MD. President, Academic Drug Discovery Consortium.
Talk: “The Role of Academic Drug Discovery”
Otis Webb Brawley
M.D. Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society. Atlanta, GA
Talk: “Foundations are the Foundation of Cancer Research”
University of Virginia Inn at Darden
Phone: (434) 243-5000